Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Resino

Showing results (111-120 of 418) with videos related to

Pageof 42
Sort By:
Plos One|June 16, 2017
Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy eraAlejandro Alvaro-Meca, Juan Berenguer, Asunción Díaz, et al.
BMC Infectious Diseases|March 17, 2016
Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unitAlejandro Álvaro-Meca, María A Jiménez-Sousa, Alexandre Boyer, et al.
Pediatric Neurology|November 25, 2003
Neuroprotective effects of early antiretrovirals in vertical HIV infectionSilvia Sánchez-Ramón, Salvador Resino, José M Bellón Cano, et al.
Pediatric Research|January 23, 2003
CD8+ T-cell numbers predict the response to antiviral therapy in HIV-1-infected childrenSlavador Resino, José Maria Bellón, Silvia Sánchez-Ramón, et al.
Medicina Clinica|December 19, 2002
[Responses to antiretroviral treatments in vertically HIV-1-infected children]Salvador Resino, José M Bellón, Dolores Gurbindo, et al.
Medicina Clinica|April 19, 2003
[Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children]Salvador Resino, Silvia Sánchez-Ramón, Rafael Correa, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 31, 2002
Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatmentsS Resino, J M Bellón, D Gurbindo, et al.
Clinical and Experimental Immunology|August 24, 2004
HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapyS Resino, I Galán, A Pérez, et al.
Medicina Clinica|January 6, 2001
[Prognostic markers of progression to AIDS in infants vertically infected by human immunodeficiency virus type-1]S Resino, J M Bellón, D Gurbindo, et al.
Clinical and Experimental Immunology|January 10, 2003
Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markersS Resino, M L Abad, J Navarro, et al.
Pageof 42

Showing results (111-120 of 418) with videos related to

Sort By:
Pageof 42
Plos One|June 16, 2017
Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy eraAlejandro Alvaro-Meca, Juan Berenguer, Asunción Díaz, et al.
BMC Infectious Diseases|March 17, 2016
Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unitAlejandro Álvaro-Meca, María A Jiménez-Sousa, Alexandre Boyer, et al.
Pediatric Neurology|November 25, 2003
Neuroprotective effects of early antiretrovirals in vertical HIV infectionSilvia Sánchez-Ramón, Salvador Resino, José M Bellón Cano, et al.
Pediatric Research|January 23, 2003
CD8+ T-cell numbers predict the response to antiviral therapy in HIV-1-infected childrenSlavador Resino, José Maria Bellón, Silvia Sánchez-Ramón, et al.
Medicina Clinica|December 19, 2002
[Responses to antiretroviral treatments in vertically HIV-1-infected children]Salvador Resino, José M Bellón, Dolores Gurbindo, et al.
Medicina Clinica|April 19, 2003
[Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children]Salvador Resino, Silvia Sánchez-Ramón, Rafael Correa, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 31, 2002
Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatmentsS Resino, J M Bellón, D Gurbindo, et al.
Clinical and Experimental Immunology|August 24, 2004
HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapyS Resino, I Galán, A Pérez, et al.
Medicina Clinica|January 6, 2001
[Prognostic markers of progression to AIDS in infants vertically infected by human immunodeficiency virus type-1]S Resino, J M Bellón, D Gurbindo, et al.
Clinical and Experimental Immunology|January 10, 2003
Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markersS Resino, M L Abad, J Navarro, et al.
Pageof 42